CA: A Cancer Journal for Clinicians

Vol. 75, Issue 3 Issue 3 2025
9
Articles

Articles in this Issue

Active monitoring of DCIS shows promise in short‐term study

Carrie Printz Jun 01, 2025 pp. 174-176 10.3322/caac.70013

Livebirth rates significantly lower among women diagnosed with cancer

Carrie Printz Jun 01, 2025 pp. 171-173 10.3322/caac.70012

From success to sustained action: Tobacco control must remain a priority

Vani N. Simmons, Jhanelle E. Gray Jun 01, 2025 pp. 180-182 10.3322/caac.70010

Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine

Malik E. Juweid, Soud F. Al‐Qasem, Fadlo R. Khuri et al. Jun 01, 2025 pp. 226-242 10.3322/caac.70007

Abstract Cancer molecular imaging is the noninvasive visualization of a process unique to or altered in neoplasia, such as proliferation, glucose metabolism, and receptor expression,...

Averted lung cancer deaths due to reductions in cigarette smoking in the United States, 1970–2022

Farhad Islami, Nigar Nargis, Qinran Liu et al. Jun 01, 2025 pp. 216-225 10.3322/caac.70005

Abstract Lung cancer mortality rates in the United States have declined steeply in recent decades, largely because of substantial reductions in smoking prevalence, as approximately 8...

Treatment adaptation based on response to induction chemotherapy in nasopharyngeal carcinoma: An evolving landscape

Nadia A. Saeed, Annie W. Chan Jun 01, 2025 pp. 177-179 10.3322/caac.70004

Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy

Kenneth J. Pienta, Patrick L. Goodin, Sarah R. Amend Jun 01, 2025 pp. 183-202 10.3322/caac.70000

Abstract Despite the advances in cancer prevention, early detection, and treatments, all of which have led to improved cancer survival, globally, there is an increased incidence in c...

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

Jun 01, 2025 pp. 203-215 10.3322/caac.21881

Abstract Background Nearly 90% locoregionally advanced nasopharyngeal carcinoma (LANPC) responds to induction chemotherapy (IC) with signific...

Novel clinical trial designs emerging from the molecular reclassification of cancer

Mina Nikanjam, Shumei Kato, Teresa Allen et al. Jun 01, 2025 pp. 243-267 10.3322/caac.21880

Abstract Next‐generation sequencing has revealed the disruptive reality that advanced/metastatic cancers have complex and individually distinct genomic landscape...

All Issues

Journal Info

Publisher Wiley
ISSN 0007-9235
E-ISSN 1542-4863
Subject Medicine
Language English
View Full Journal Page